Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan W Dellinger

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 21, 2016
Detection of Total UDP-Glucuronosyltransferase (UGT) Activity in Melanoma CellsRyan W Dellinger, Frank L Meyskens
Nutrients|July 14, 2023
Defining NAD(P)(H) CatabolismJyothi Dhuguru, Ryan W Dellinger, Marie E Migaud
Journal of Photochemistry and Photobiology. B, Biology|July 16, 2014
Continuing to illuminate the mechanisms underlying UV-mediated melanomagenesisRyan W Dellinger, Feng Liu-Smith, Frank L Meyskens
Drug Metabolism and Pharmacokinetics|August 23, 2013
Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differencesRyan W Dellinger, Angela M Gomez Garcia, Frank L Meyskens
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2009
UDP-glucuronosyltransferase 1A10: activity against the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibilityRene M Balliet, Gang Chen, Ryan W Dellinger, et al.
Anti-Cancer Drugs|July 11, 2003
NB1011 induces Ser15 phosphorylation of p53 and activates the G2/M checkpointRyan W Dellinger, Patricia L Karjian, Saskia T C Neuteboom
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2006
Importance of UDP-glucuronosyltransferase 1A10 (UGT1A10) in the detoxification of polycyclic aromatic hydrocarbons: decreased glucuronidative activity of the UGT1A10139Lys isoformRyan W Dellinger, Jia-Long Fang, Gang Chen, et al.
Pharmacogenetics and Genomics|February 28, 2008
Identification of a prevalent functional missense polymorphism in the UGT2B10 gene and its association with UGT2B10 inactivation against tobacco-specific nitrosaminesGang Chen, Ryan W Dellinger, Carla J Gallagher, et al.
Pharmacogenetics and Genomics|August 11, 2010
Characterization of 17-dihydroexemestane glucuronidation: potential role of the UGT2B17 deletion in exemestane pharmacogeneticsDongxiao Sun, Gang Chen, Ryan W Dellinger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 2, 2008
Glucuronidation of tobacco-specific nitrosamines by UGT2B10Gang Chen, Ryan W Dellinger, Dongxiao Sun, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|January 21, 2016
Detection of Total UDP-Glucuronosyltransferase (UGT) Activity in Melanoma CellsRyan W Dellinger, Frank L Meyskens
Nutrients|July 14, 2023
Defining NAD(P)(H) CatabolismJyothi Dhuguru, Ryan W Dellinger, Marie E Migaud
Journal of Photochemistry and Photobiology. B, Biology|July 16, 2014
Continuing to illuminate the mechanisms underlying UV-mediated melanomagenesisRyan W Dellinger, Feng Liu-Smith, Frank L Meyskens
Drug Metabolism and Pharmacokinetics|August 23, 2013
Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differencesRyan W Dellinger, Angela M Gomez Garcia, Frank L Meyskens
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2009
UDP-glucuronosyltransferase 1A10: activity against the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibilityRene M Balliet, Gang Chen, Ryan W Dellinger, et al.
Anti-Cancer Drugs|July 11, 2003
NB1011 induces Ser15 phosphorylation of p53 and activates the G2/M checkpointRyan W Dellinger, Patricia L Karjian, Saskia T C Neuteboom
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2006
Importance of UDP-glucuronosyltransferase 1A10 (UGT1A10) in the detoxification of polycyclic aromatic hydrocarbons: decreased glucuronidative activity of the UGT1A10139Lys isoformRyan W Dellinger, Jia-Long Fang, Gang Chen, et al.
Pharmacogenetics and Genomics|February 28, 2008
Identification of a prevalent functional missense polymorphism in the UGT2B10 gene and its association with UGT2B10 inactivation against tobacco-specific nitrosaminesGang Chen, Ryan W Dellinger, Carla J Gallagher, et al.
Pharmacogenetics and Genomics|August 11, 2010
Characterization of 17-dihydroexemestane glucuronidation: potential role of the UGT2B17 deletion in exemestane pharmacogeneticsDongxiao Sun, Gang Chen, Ryan W Dellinger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 2, 2008
Glucuronidation of tobacco-specific nitrosamines by UGT2B10Gang Chen, Ryan W Dellinger, Dongxiao Sun, et al.
Pageof 5